Related references
Note: Only part of the references are listed.Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: A long-term outcome of two siblings
Danijela Petkovic Ramadza et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2021)
Clinical evaluation of sibling pairs with gaucher disease discordant for parkinsonism
Grisel Lopez et al.
MOVEMENT DISORDERS (2020)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Laurie A. Robak et al.
BRAIN (2017)
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
Aya Narita et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Parkinsonism and inborn errors of metabolism
A. Garcia-Cazorla et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders
Ozlem Goker-Alpan et al.
ACTA NEUROPATHOLOGICA (2010)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann et al.
BRAIN (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Early-onset severe neurological involvement and D409H homozygosity in Gaucher disease: outcome of enzyme replacement therapy
H Michelakakis et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
Share Paper
